Author

Giorgio Cannetti

Observed name: G. Cannetti

Institutions: Azienda Ospedaliero-Universitaria Careggi, University of Florence

Observed institutions: Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic, Azienda Ospedaliero-Universitaria Careggi, Istituti di Ricovero e Cura a Carattere Scientifico, University of Florence

ORCID: 0000-0002-3243-8213

Observed ORCID: 0000-0002-3243-8213

OpenAlex ID: A5028078311

Differences in Cerebral Tissue Oxygenation in Preterm Neonates Receiving Adult or Cord Blood Red Blood Cell Transfusions

2023 · Claudio Pellegrino, Patrizia Papacci, et al. · JAMA Network Open · 28

Single shot of intravenous iron in cardiac surgery: The ICARUS study

2022 · Filippo Corsi, Annalisa Pasquini, et al. · Journal of Clinical Anesthesia · 11

AML-558: Low Rate of Fungal Infections in a Population of Elderly/Unfit AML Patients Receiving Azacitidine and Venetoclax Without Posaconazole Prophylaxis: A Monocentric Experience

2025 · Matteo Piccini, Giorgio Cannetti, et al. · Clinical Lymphoma Myeloma & Leukemia · 1

AML-555: MYC-Rearranged Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report

2025 · Giorgio Cannetti, Barbara Scappini, et al. · Clinical Lymphoma Myeloma & Leukemia · 1

Clofarabine and intermediate-dose cytarabine after venetoclax failure in relapsed/refractory acute myeloid leukemia: a retrospective single-center experience

2026 · Gaia Ciolli, Matteo Piccini, et al. · Research Square

Clinical Experience With Venetoclax‐Based Combinations for Relapsed/Refractory or MRD ‐Positive NPM1 ‐Mutated Acute Myeloid Leukemia

2026 · Matteo Piccini, Naseema Gangat, et al. · American Journal of Hematology

POSTER: AML-558 Low Rate of Fungal Infections in a Population of Elderly/Unfit AML Patients Receiving Azacitidine and Venetoclax Without Posaconazole Prophylaxis: A Monocentric Experience

2025 · Matteo Piccini, Giorgio Cannetti, et al. · Clinical Lymphoma Myeloma & Leukemia

Works count: 8

Citation count: 41

H-index: 2

I10-index: 2